Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Praziquantel paediatric formulation - Pediatric Praziquantel Consortium

Drug Profile

Praziquantel paediatric formulation - Pediatric Praziquantel Consortium

Alternative Names: L-praziquantel; L-praziquantel orodispersible; L-PZQ; L-PZQ ODT; MSC-1028703; MSC-1028703A; MSC-2499550A; PZQ ODT; Rac-PZQ ODT; Racemate PZQ ODT

Latest Information Update: 21 Nov 2019

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Pediatric Praziquantel Consortium
  • Class 3-ring heterocyclic compounds; Anthelmintics; Cyclohexanes; Isoquinolines; Pyrazines; Small molecules
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase III Schistosomiasis

Most Recent Events

  • 02 Sep 2019 Phase-III clinical trials in Schistosomiasis (In infants, In children) in Ivory Coast, Kenya (PO) (NCT03845140)
  • 17 Nov 2018 Merck KGaA completes a phase II trial in Schistosomiasis (In children, In infants) in Germany (PO) (NCT02806232)
  • 24 Jun 2018 Biomarkers information updated
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top